Nutrition Industry Executive (NIE) asked Jennifer Clancy, global marketing director for Nutriventia (Mumbai, India and Westfield, NJ), to share a case study on bringing a new ingredient to market.

NIE: Please outline a case study of bringing a new ingredient to market, including pre-launch and post-launch planning.

Clancy: When introducing a new ingredient, Nutriventia follows a comprehensive and strategic approach. Here’s a detailed case study of how we brought TurmXTRA 60N, an award-winning turmeric-based ingredient, to market with unparalleled support for joint and muscle health.

Case Study: Bringing TurmXTRA to Market

1. Identifying Market Needs and Consumer Trends

The process begins with thorough market research and analysis. For TurmXTRA 60N, we conducted the following key studies:

• Consumer Demand Analysis: Identified a rising interest in natural

• Competitive Landscape Assessment: Analyzed existing turmeric-based products and their market performance, noting gaps in bioavailability and efficacy.

• Trend Analysis: Monitored global health trends showing increased consumer preference for bioavailable supplements and natural remedies.

2. Defining the Unique Selling Proposition (USP)

Next, we determined the unique selling proposition (USP) of TurmXTRA 60N. The USP for TurmXTRA 60N is its award-winning support for joint and muscle health, backed by the world’s best 250mg curcuminoids formulation suitable for every format. Its proven efficacy and enhanced bioavailability, as evidenced by:

3 PK Studies: Demonstrating significantly higher absorption rates compared to standard turmeric extracts. NEW TurmXTRA vs C3 Study Study-specific claims

Primary Objective:

To assess the bioavailability between Test Product (T): TurmXTRA 60N Capsule 250 mg (containing 150 mg of curcuminoids from Water Dispersible Turmeric Extract, 1 x 250 mg) manufactured by Nutriventia Limited, and Reference Product (R): Turmeric extract Capsules (containing 500 mg of C3 Complex curcuminoids and 5 mg bioperine, 3 x 500 mg, one capsule 6 hourly)  manufactured by Sami-Sabinsa Group Limited, India in normal, healthy, adult, human subjects under fasting conditions.

• 2 Clinical Studies: Showing marked improvements in joint health and reduction of Delayed Onset Muscle Soreness (DOMS).

• 20+ Meta-Analysis & Systematic Reviews: Consolidating extensive research to validate its safety and effectiveness.

3. Conducting Scientific Research and Validation

We invested heavily in scientific research to validate the benefits of TurmXTRA 60N. Key studies included:

• Bioavailability Studies: Conducted four pharmacokinetic (PK) studies demonstrating TurmXTRA 60N’s superior absorption.

• Clinical Trials: Two clinical studies provided robust evidence of TurmXTRA 60N’s efficacy in promoting joint health and reducing DOMS.

• Meta-Analysis & Systematic Reviews: Over 20 studies were analyzed to ensure a comprehensive understanding of the ingredient’s impact.

4. Market Introduction and Education

With validated data, we developed a unique and comprehensive marketing strategy tailored specifically for TurmXTRA 60N. This included:

• Training Materials: Developed engaging and informative ingredient videos and tutorials to educate internal teams on the unique benefits and scientific backing of TurmXTRA 60N.

• Detailed Presentations: Created in-depth presentations for industry conferences and trade shows, highlighting the unique attributes and scientific validation of TurmXTRA 60N.

• Claims Dossiers: Compiled comprehensive claims dossiers with detailed evidence from our studies to ensure all marketing communications are accurate and consistent.

• Customer-Facing Materials: Prepared a visually appealing and informative claims deck to effectively communicate the benefits and USP of TurmXTRA 60N to potential customers and partners.

5. Continuous Monitoring and Adaptation

After introducing TurmXTRA 60N to the market, we continuously monitored its performance and gathered feedback. This ongoing analysis involved:

• Sales Data Analysis: Tracked sales figures to gauge market acceptance and identify areas for improvement.

• Customer Feedback: Collected and analyzed feedback from customers to understand their experiences and satisfaction with TurmXTRA 60N.

• Market Trends Monitoring: Kept an eye on emerging trends and competitor activities to stay ahead in the market.

• Adaptation Strategies: Refined our marketing and sales strategies based on feedback and performance data to better meet market expectations.

Conclusion

Through this methodical approach, Nutriventia ensures that each new ingredient, like TurmXTRA 60N, is not only scientifically validated but also aligns with market demands and offers a clear competitive advantage. This comprehensive strategy has been key to our success in introducing innovative and effective ingredients to the market.

Feature